Pharmacyte Biotech Addressing Unmet Need In Patients With Lapc As Pancreatic Cancer 5year Survival Rate Increases To 10 | Latest News RSS feed

Pharmacyte Biotech Addressing Unmet Need In Patients With Lapc As Pancreatic Cancer 5year Survival Rate Increases To 10 - Latest News


PharmaCyte Biotech Addressing Unmet Need in Patients with LAPC as Pancreatic Cancer 5-Year Survival Rate Increases to 10%

NEW YORK, NY, Jan. 14, 2020 (GLOBE NEWSWIRE) -- This month the American Cancer Society announced that for the first time ever, the 5-year survival rate for pancreatic cancer has reached double digits. read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us